MedPath

Measuring the endothelial function of Patients after COVID-19 Disease via retinal dynamic vessel analyzer

Recruiting
Conditions
09.9
Registration Number
DRKS00027891
Lead Sponsor
niversitätsklinikum Jena
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Long COVID Syndrom
Minimum of 1 pos. PCR Test (Sars-CoV-19) before onset of symptoms

Exclusion Criteria

none

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Parameters of dynamic RVA are significantly reduced comapred to normal values.
Secondary Outcome Measures
NameTimeMethod
Comparison of degree of symptoms (measured by EQ5D) verus lung function tests versus DVA<br>Regression analysis with known cnonfounders (age, cardiovascular diesease, medications)<br>Comparison of static vessel analyzer data versus normal collective<br>subgroup analysis of regarding form of lung function abnormalities (Vascular vs interstitial vs normal)
© Copyright 2025. All Rights Reserved by MedPath